Head-to-head · Cost-Efficiency Index
Virta Health vs G-Plans
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Virta Health
Cost-first shoppers who want employees/members with type 2 diabetes or metabolic syndrome whose employer/health plan sponsors Virta.
Visit Virta HealthG-Plans
Shoppers wanting a nutrition/genotype-assessment angle alongside optional GLP-1 access, willing to complete a quiz to see pricing.
Visit G-PlansThe verdict
Virta Health takes it, leading the Cost-Efficiency Index 43 to 42. Virta Health is a nutrition-first, diabetes-reversal and metabolic-health platform, not a primary GLP-1 prescriber -- its own marketing positions its program as a complement to or 'offramp' from weight-loss medications. G-Plans still earns a C — Shoppers wanting a nutrition/genotype-assessment angle alongside optional GLP-1 access, willing to complete a quiz to see pricing.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Virta Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Virta Health | G-Plans |
|---|---|---|
| Cost-Efficiency Index | 43/100 | 42/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #506 | #512 |
Virta Health
43/100Where the value is
- Strong clinical evidence base for nutrition-driven diabetes reversal
- Positions itself as a long-term alternative to lifelong medication dependence
- Enterprise-grade platform backed by employer and health-plan contracts
The tradeoffs
- Not primarily a GLP-1 prescribing service -- medications are secondary to the nutrition program
- No direct-to-consumer, cash-pay enrollment exists
G-Plans
42/100Where the value is
- LegitScript badge displayed
- Confirmed access to both branded (Ozempic) and compounded GLP-1 medications
- Distinctive nutrition-first / metabolic-genotype assessment angle vs. pure drug-dispensing competitors
The tradeoffs
- Zero pricing visible anywhere without completing the full intake quiz
- No named medical director or compounding pharmacy partner
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.